Health Canada to Spot Check Medical Marijuana After Recall

Subscribe
February 9, 2017

Health Canada says it will begin random testing of medical marijuana products to check for the presence of banned pesticides after product recalls affecting nearly 25,000 customers led to reports of illnesses and the possibility of a class action lawsuit.

RELATED: No Required Pesticide Testing for Cannabis, Health Canada Says

Late last year, licensed medical marijuana producers Organigram of Moncton, N.B., and Toronto-based Mettrum voluntarily recalled products due to the presence of low levels of the prohibited chemicals myclobutanil, bifenazate and pyrethrins, all of which are prohibited in tobacco and marijuana.

In January, nearly all of Organigram's products sold in 2016 were pulled in a higher-level voluntary recall.

Read more.